KCGI
KCGI is a venture capital firm based in Seoul, South Korea, focused on Late Stage startups. This profile covers its focus and how founders can get in front of it in 2026.
KCGI is a South Korean private equity firm.
- Investment stages
- Late Stage
- Location
- Seoul, South Korea
- Team size
- 1-10
- Latest deal on record
- March 2026
How to pitch KCGI
The founders who hear back from KCGI lead with traction and a clear ask that matches its stage, not a generic mass email. Build a targeted, verified list, write a personalized note, and track who opens it, all in one place.
Connect with KCGI
About this profile
This profile is part of Round Funded, an investor database and outreach platform for founders. It covers 60,000+ active VCs, angels, family offices and accelerators with verified contacts, lets you send pitches from your own Gmail, and includes a free Data Room for your raise. How this data is built.
Cite this page
Round Funded. "KCGI." Round Funded investor database, updated October 19, 2026.
Stable URL, it will not change: https://www.roundfunded.com/en/vc/kcgi
Frequently Asked Questions
What is KCGI?
KCGI is a venture capital firm based in Seoul, South Korea. Round Funded tracks its focus, stage, and activity alongside thousands of active investors.
What stage does KCGI invest at?
KCGI focuses on Late Stage rounds. Lead with traction that fits the stage when you reach out.
Where is KCGI based?
KCGI is based in Seoul, South Korea. You can reach out from anywhere with a pitch that matches its focus.
How do I contact KCGI?
Unlock a verified email for KCGI and reach out with a personalized pitch on Round Funded. We show only deliverable contacts, so your outreach does not bounce.
What is Round Funded?
Round Funded is an investor database and outreach platform for startup founders. It lists 60,000+ active investors with verified contacts, filtered to recent investment activity, and lets founders send personalized pitches from their own Gmail, track replies, and share a free Data Room. Round+ starts at $99 per month with a 3-day trial.